PATENT CLAIM ANALYSIS

Application Number: 15974184
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["514", "415000"]

Abstract:
Methods that include determining levels of melatonin pathway agents (melatonin, L-tryptophan, 5-hydroxytryptophan (5-HTP), serotonin, N-acetylserotonin (NAS), and melatonin receptor 1A (MT1)) in Hypoxic-ischemic brain injury in both newborns (HIE) and adults (stroke), and in ALS, and optionally administering these agents to treat these conditions.

Claim (Index 9):
The method of  claim 6 , wherein the treatment comprises administration of hypothermia.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 93.0
- Lexical Diversity: 1.64103
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14963676', '14395465', '13726416', '14009276', '12232141']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7818583251281596
- 35 USC 102 Novelty (BERT): 0.5210702706109551
- Combined Prediction Score: 0.7557795196764391
- Mean Citation Score: 257.620224
- Max Citation Score: 274.2318
- Similarity Product: 153.93612740836144

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test